Cargando…

Response to Neoadjuvant Therapy and Prognosis in Patients with Resectable Pancreatic Cancer: A Propensity Score Matching Analysis

BACKGROUND/AIMS: Controversy regarding the effectiveness of neoadjuvant therapy for resectable pancreatic ductal adenocarcinoma (PDAC) still exists. Here, we aimed to identify the potential benefits of neoadjuvant therapy followed by surgery for resectable PDAC. METHODS: We reviewed radiologically r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoon, Min Sung, Lee, Hee Seung, Kang, Chang Moo, Lee, Woo Jung, Keum, Jiyoung, Sung, Min Je, Kim, Seung-seob, Park, Mi-Suk, Jo, Jung Hyun, Chung, Moon Jae, Park, Jeong Youp, Park, Seung Woo, Song, Si Young, Hwang, Ho Kyoung, Bang, Seungmin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Editorial Office of Gut and Liver 2022
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8761915/ https://www.ncbi.nlm.nih.gov/pubmed/34140428 http://dx.doi.org/10.5009/gnl20301

Ejemplares similares

Usefulness of Smartphone Apps for Improving Nutritional Status of Pancreatic Cancer Patients: Randomized Controlled Trial
por: Keum, Jiyoung, et al.
Publicado: (2021)

Evaluation of the 8th Edition AJCC Staging System for the Clinical Staging of Pancreatic Cancer
por: Kang, Huapyong, et al.
Publicado: (2022)

Impact of UGT1A1 Polymorphisms on Febrile Neutropenia in Pancreatic Cancer Patients Receiving FOLFIRINOX: A Single-Center Cohort Study
por: Keum, Jiyoung, et al.
Publicado: (2022)

Clinical Outcomes of Neoadjuvant Chemotherapy in Colorectal Cancer Patients With Synchronous Resectable Liver Metastasis: A Propensity Score Matching Analysis
por: Park, Sung Hae, et al.
Publicado: (2021)

Benefit of neoadjuvant concurrent chemoradiotherapy for locally advanced perihilar cholangiocarcinoma
por: Jung, Jang Han, et al.
Publicado: (2017)

Validation of Group B Borderline Resectable Pancreatic Cancer: Retrospective Analysis
por: Oh, Tak Geun, et al.
Publicado: (2014)

The Role of Neoadjuvant Chemoradiation Therapy in Patients With Borderline Resectable Pancreatic Cancer With Isolated Venous Vascular Involvement
por: Lee, Jin Ho, et al.
Publicado: (2015)

Prognostic Factors in Patients Treated with Pembrolizumab as a Second-Line Treatment for Advanced Biliary Tract Cancer
por: Park, Chan Su, et al.
Publicado: (2022)

Adjuvant radiotherapy for the treatment of stage IV rectal cancer after curative resection: A propensity score-matched analysis and meta-analysis
por: Kim, Min Jung, et al.
Publicado: (2016)

Potential Impact of Phellinus linteus on Adherence to Adjuvant Treatment After Curative Resection of Pancreatic Ductal Adenocarcinoma: Outcomes of a Propensity Score–Matched Analysis
por: Lee, Sung Hwan, et al.
Publicado: (2018)

Impact of cholecystectomy on acute coronary syndrome according to metabolic condition: a nationwide population-based cohort study
por: Chae, Wonjeong, et al.
Publicado: (2023)

Outcomes of simultaneous laparoscopic, hybrid, and open resection in colorectal cancer with synchronous liver metastases: a propensity score-matched study
por: Lim, Han-Ki, et al.
Publicado: (2022)

Comparison of efficacy and safety between standard-dose and modified-dose FOLFIRINOX as a first-line treatment of pancreatic cancer
por: Kang, Huapyong, et al.
Publicado: (2018)

A novel lumen-apposing metal stent with an anti-reflux valve for endoscopic ultrasound-guided drainage of pseudocysts and walled-off necrosis: A pilot study
por: Cho, In Rae, et al.
Publicado: (2019)

BRCA 1/2 Germline Mutation Predicts the Treatment Response of FOLFIRINOX with Pancreatic Ductal Adenocarcinoma in Korean Patients
por: Park, Ji Hoon, et al.
Publicado: (2022)

Analysis of Clinical Predictive Factors Affecting the Outcome of Second-Line Chemotherapy for Gemcitabine-Refractory Advanced Pancreatic Cancer
por: Lee, Jeung Eun, et al.
Publicado: (2020)

FOLFIRINOX vs gemcitabine/nab-paclitaxel for treatment of metastatic pancreatic cancer: Single-center cohort study
por: Cho, In Rae, et al.
Publicado: (2020)

An optimal transition time to extracorporeal cardiopulmonary resuscitation for predicting good neurological outcome in patients with out-of-hospital cardiac arrest: a propensity-matched study
por: Kim, Su Jin, et al.
Publicado: (2014)

Urgent endoscopic retrograde cholangiopancreatography is not superior to early ERCP in acute biliary pancreatitis with biliary obstruction without cholangitis
por: Lee, Hee Seung, et al.
Publicado: (2018)

Bleeding Complications and Clinical Safety of Endoscopic Retrograde Cholangiopancreatography in Patients with Liver Cirrhosis
por: Kim, Ji Yeon, et al.
Publicado: (2019)

Profiling of conditionally reprogrammed cell lines for in vitro chemotherapy response prediction of pancreatic cancer
por: Lee, Hee Seung, et al.
Publicado: (2021)

A phase I/II study of ivaltinostat combined with gemcitabine and erlotinib in patients with untreated locally advanced or metastatic pancreatic adenocarcinoma
por: Jo, Jung Hyun, et al.
Publicado: (2022)

Radiotherapy Prolongs Biliary Metal Stent Patency in Malignant Pancreatobiliary Obstructions
por: Park, Semi, et al.
Publicado: (2013)

Oncologic outcomes after radical surgery for periampullary cancer in octogenarians
por: Kim, Sung Hyun, et al.
Publicado: (2018)

Risk Factors Associated with Loco-Regional Failure after Surgical Resection in Patients with Resectable Pancreatic Cancer
por: Kim, Hyun Ju, et al.
Publicado: (2016)

Long-term outcomes of fully covered self-expandable metal stents versus plastic stents in chronic pancreatitis
por: Lee, Sang Hoon, et al.
Publicado: (2021)

Statin Use and Its Impact on Survival in Pancreatic Cancer Patients
por: Lee, Hee Seung, et al.
Publicado: (2016)

The Expression of Programmed Death-Ligand 1 on Immune Cells Is Related to a Better Prognosis in Biliary Tract Cancer
por: Kwon, Sung Chan, et al.
Publicado: (2023)

Clinical characteristics of second primary pancreatic cancer
por: Jo, Jung Hyun, et al.
Publicado: (2017)

Establishment of pancreatic cancer cell lines with endoscopic ultrasound‐guided biopsy via conditionally reprogrammed cell culture
por: Lee, Hee Seung, et al.
Publicado: (2019)

Gastrointestinal Hemorrhage after Concurrent Chemoradiotherapy in Locally Advanced Pancreatic Cancer
por: Lee, Kyong Joo, et al.
Publicado: (2013)

Regional lymph node metastasis detected on preoperative CT and/or FDG-PET may predict early recurrence of pancreatic adenocarcinoma after curative resection
por: Yoon, Ja Kyung, et al.
Publicado: (2022)

Endoscopic Papillary Balloon Dilation with Large Balloon after Limited Sphincterotomy for Retrieval of Choledocholithiasis
por: Bang, Seungmin, et al.
Publicado: (2006)

Pancreatoduodenectomy following neoadjuvant chemotherapy in duodenal adenocarcinoma
por: Seo, Dongjin, et al.
Publicado: (2023)

Phase II Trial of Erlotinib Plus Gemcitabine Chemotherapy in Korean Patients with Advanced Pancreatic Cancer and Prognostic Factors for Chemotherapeutic Response
por: Park, Semi, et al.
Publicado: (2013)

Should the Splenic Vein Be Preserved—Fate of Sinistral Portal Hypertension after Pancreatoduodenectomy with Vascular Re-Section for Pancreatic Cancer
por: Kim, Sung Hyun, et al.
Publicado: (2022)

Concomitant Statin Use Has a Favorable Effect on Gemcitabine-Erlotinib Combination Chemotherapy for Advanced Pancreatic Cancer
por: Moon, Do Chang, et al.
Publicado: (2016)

[6]-Gingerol Induces Cell Cycle Arrest and Cell Death of Mutant p53-expressing Pancreatic Cancer Cells
por: Park, Yon Jung, et al.
Publicado: (2006)

Effect of Neoadjuvant Hormone Therapy on Resection Margin and Survival Prognoses in Locally Advanced Prostate Cancer after Prostatectomy Using Propensity-Score Matching
por: Kim, Sung Han, et al.
Publicado: (2018)

Peripheral Nerve Blockade in Total Hip Arthroplasty: A Retrospective Study with Propensity Score Matching
por: Kwon, Hyuck Min, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_s0lbe2hrc0dk64jlpm6391guu5